ELIZABETH HEAD: Open Payments
NPI 1811729478 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,280 in 56 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $433 · 2025 $1,280
Food & beverage: $1,280
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $240 |
| Merck Sharp & Dohme LLC | 9 | $216 |
| Janssen Biotech, Inc. | 3 | $95 |
| Novo Nordisk Inc | 1 | $87 |
| Geron Corporation | 3 | $77 |
| ABBVIE INC. | 4 | $72 |
| Daiichi Sankyo Inc. | 2 | $51 |
| Syndax Pharmaceuticals, Inc. | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| SERVIER PHARMACEUTICALS LLC | 2 | $39 |
Products named: KEYTRUDA, Ozempic, SCEMBLIX, RYTELO, KISQALI, Fabhalta, ERLEADA, REVUFORJ.
Industry payments across IN — which companies pay providers there.
